主要研究领域为基于大型队列和电子病历数据库的慢性病流行病学与药物流行病学。
暂未填写
1. Zheng B, Green ACA, Tazare J, et al. Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe COVID-19 outcomes in patients in the community: observational cohort study with the OpenSAFELY platform. BMJ. 2022,379:e071932.
2. Zheng B, Kurdi A, Amstutz A, et al. Tocilizumab versus sarilumab among adults hospitalised with COVID-19: target trial emulation across England and Scotland. Nature Communications. 2026 (Accepted for publication).
3. Zheng B, Su B, Price G, et al. Glycaemic control, diabetic complications and risk of dementia in patients with diabetes: results from a large UK cohort study. Diabetes Care. 2021,44(7):1556-1563.
4. Zheng B, Tazare J, Nab L, et al. Comparative effectiveness of nirmatrelvir/ritonavir versus sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised high-risk patients during Omicron waves: observational cohort study using the OpenSAFELY platform. Lancet Regional Health – Europe. 2023,34:100741.
5. Zheng B*, Vivaldi G*, Daines L, et al. Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls. Lancet Regional Health – Europe. 2023,29:100635. * Co-first author.
6. Zheng B, Su B, Ahmadi-Abhari S, et al. Dementia risk in patients with type 2 diabetes: comparing Metformin with no pharmacological treatment. Alzheimer's & Dementia. 2023,19(12):5681-5689.
7. Charpignon M*, Vakulenko-Lagun B*, Zheng B*, et al. Causal inference in medical records and complementary systems pharmacology for metformin drug repurposing towards dementia. Nature Communications. 2022;13:7652. * Co-first author
8. Han Q, Zheng B*, Cristea M, et al. Trust in government regarding COVID-19 and its associations with preventive health behaviour and prosocial behaviour during the pandemic: a cross-sectional and longitudinal study. Psychological Medicine. 2023,53(1):149-159. * Corresponding author.
9. Zheng B, Tal R, Yang ZR, et al. Cortisol hypersecretion and the risk of Alzheimer’s disease: a systematic review and meta-analysis. Ageing Research Reviews. 2020,64:101171.
10. Zheng B, Yu C, Lv J, et al.; China Kadoorie Biobank Collaborative Group. Insomnia symptoms and risk of cardiovascular diseases among 0.5 million adults: a 10-year cohort. Neurology. 2019,93(23):e2110-e2120.